Healthcare provider profile · identity verified

Neil M Olsen, MD

Family Practice · CENTRAL POINT, OR · NPI 1942396676

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	703	191
Levothyroxine Sodium	Levothyroxine Sodium	394	98
Amlodipine Besylate	Amlodipine Besylate	388	102
Lisinopril	Lisinopril	288	83
Omeprazole	Omeprazole	228	62
Gabapentin	Gabapentin	188	41
Rosuvastatin Calcium	Rosuvastatin Calcium	182	52
Metoprolol Succinate	Metoprolol Succinate	170	55
Losartan Potassium	Losartan Potassium	167	49
Tamsulosin Hcl	Tamsulosin Hcl	161	43
Metformin Hcl	Metformin Hcl	158	44
Fluoxetine Hcl	Fluoxetine Hcl	147	30
Potassium Chloride	Potassium Chloride	146	41
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	139	46
Pravastatin Sodium	Pravastatin Sodium	138	38
Metformin Hcl Er	Metformin Hcl	126	37
Tizanidine Hcl	Tizanidine Hcl	126	27
Trazodone Hcl	Trazodone Hcl	125	29
Eliquis	Apixaban	122	29
Furosemide	Furosemide	119	37
Pantoprazole Sodium	Pantoprazole Sodium	117	25
Carvedilol	Carvedilol	115	34
Duloxetine Hcl	Duloxetine Hcl	101	30
Albuterol Sulfate Hfa	Albuterol Sulfate	100	27
Hydrochlorothiazide	Hydrochlorothiazide	97	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	22
Allopurinol	Allopurinol	91	22
Clopidogrel	Clopidogrel Bisulfate	90	22
Xarelto	Rivaroxaban	86	23
Donepezil Hcl	Donepezil Hcl	82	16
Alendronate Sodium	Alendronate Sodium	75	21
Glipizide Er	Glipizide	74	24
Simvastatin	Simvastatin	72	19
Sertraline Hcl	Sertraline Hcl	71	19
Ozempic	Semaglutide	69	14
Citalopram Hbr	Citalopram Hydrobromide	62	11
Escitalopram Oxalate	Escitalopram Oxalate	62	17
Famotidine	Famotidine	62	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	suppressed
Warfarin Sodium	Warfarin Sodium	58	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	15
Metoprolol Tartrate	Metoprolol Tartrate	57	17
Lovastatin	Lovastatin	56	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Bupropion Xl	Bupropion Hcl	54	13
Finasteride	Finasteride	54	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	12
Spironolactone	Spironolactone	51	14
Meloxicam	Meloxicam	46	suppressed
Montelukast Sodium	Montelukast Sodium	46	14
Buspirone Hcl	Buspirone Hcl	45	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	45	11
Jardiance	Empagliflozin	43	12
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Celecoxib	Celecoxib	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	17
Atenolol	Atenolol	32	11
Chlorthalidone	Chlorthalidone	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Baclofen	Baclofen	31	suppressed
Clonazepam	Clonazepam	31	suppressed
Colchicine	Colchicine	31	13
Prednisone	Prednisone	31	16
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	suppressed
Estradiol	Estradiol	27	suppressed
Nystatin	Nystatin	27	12
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Arnuity Ellipta	Fluticasone Furoate	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Torsemide	Torsemide	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	12
Fenofibrate	Fenofibrate	16	suppressed
Glipizide	Glipizide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Famciclovir	Famciclovir	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Diazepam	Diazepam	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error